Literature DB >> 30890684

Novel Acute Myocardial Infarction Risk Stratification (nARS) System Reduces the Length of Hospitalization for Acute Myocardial Infarction.

Kei Yamamoto1, Kenichi Sakakura1, Naoyuki Akashi1, Yusuke Watanabe1, Masamitsu Noguchi1, Masaru Seguchi1, Yousuke Taniguchi1, Yusuke Ugata1, Hiroshi Wada1, Shin-Ichi Momomura1, Hideo Fujita1.   

Abstract

BACKGROUND: The novel Acute Myocardial Infarction (AMI) Risk Stratification (nARS) system was recently developed based on original criteria. The use of nARS may reduce the length of hospitalization. Methods and 
Results: We allocated 560 AMI patients into the pre-nARS group (before adopting nARS) or the nARS group. Patients in the nARS group were subdivided into the low (L), intermediate (I), and high (H) risk groups, whereas patients in the pre-nARS group were subdivided into the equivalent L (eL), equivalent I (eI), or equivalent H (eH) risk groups based on the nARS criteria. Length of coronary care unit (CCU) stay was significantly shorter in the nARS group (2.8±3.5 days) compared with the pre-nARS group (4.4±5.4 days; P<0.001). Length of hospital stay was also shorter in the nARS group (9.4±8.9 days) compared with the pre-nARS group (13.4±12.8 days; P<0.001). Length of CCU stay was significantly shorter in the L (1.1±1.0 days), I (2.8±3.5 days), and H (5.0±4.8 days) risk groups compared with corresponding eL (2.2±1.1 days), eI (4.4±5.4 days), and eH (7.1±7.8 days) risk groups.
CONCLUSIONS: Length of CCU and hospital stay were significantly shorter in the nARS group compared with the pre-nARS group. The use of nARS may save medical resources in the treatment of AMI in the regional health-care system.

Entities:  

Keywords:  Acute myocardial infarction; Coronary care unit; Length of hospitalization; Risk stratification

Mesh:

Year:  2019        PMID: 30890684     DOI: 10.1253/circj.CJ-18-1221

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Atorvastatin combined with routine therapy on HIF-1, VEGF concentration and cardiac function in rats with acute myocardial infarction.

Authors:  Jingbin Yu; Lei Zhang; Hui Zhang
Journal:  Exp Ther Med       Date:  2020-01-27       Impact factor: 2.447

2.  Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus.

Authors:  Naoyuki Akashi; Takunori Tsukui; Kei Yamamoto; Masaru Seguchi; Yousuke Taniguchi; Kenichi Sakakura; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2021-03-14       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.